| 000 | 00663nam a2200205Ia 4500 | ||
|---|---|---|---|
| 005 | 20260808125444.0 | ||
| 008 | 260808s9999||||xx |||||||||||||| ||und|| | ||
| 020 | _a0195-7996(ISSN) | ||
| 035 | _a5277 | ||
| 041 | _aENG | ||
| 082 | _a615.11 | ||
| 100 | _aUnited States Pharmacopeial Convention Inc | ||
| 245 | 0 |
_aUnited States pharmacopoeia XXI-NFXVI _bsupplement-2 |
|
| 260 |
_aUSA _bUS Pharmacopoeia Convention Incorporation _c1985 |
||
| 300 | _a1793-1946 | ||
| 500 | _a62 & 86 & 06.03.1986 | ||
| 505 | _aUSP, United States Pharmacopoeia, drug standards, pharmaceutical reference | ||
| 650 |
_aReferences (USP) _bPharmacology -- Therapeutics |
||
| 942 | _cBK | ||
| 999 |
_c5275 _d5275 |
||